Expression, purification and characterization of a human single-chain Fv antibody fragment fused with the Fc of an IgG1 targeting a rabies antigen in Pichia pastoris.

[1]  Yongge Wu,et al.  A novel disulfide-stabilized single-chain variable antibody fragment against rabies virus G protein with enhanced in vivo neutralizing potency. , 2012, Molecular immunology.

[2]  Yang Wang,et al.  G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates. , 2011, Antiviral research.

[3]  Zhenqing Feng,et al.  Generation and characterization of the human neutralizing antibody fragment Fab091 against rabies virus , 2011, Acta Pharmacologica Sinica.

[4]  A. Nishizono,et al.  Isolation and characterization of novel human monoclonal antibodies possessing neutralizing ability against rabies virus , 2010, Microbiology and immunology.

[5]  Thomas I Potgieter,et al.  Antibody expression kinetics in glycoengineered Pichia pastoris , 2010, Biotechnology and bioengineering.

[6]  M. Unno,et al.  Application of the Fc fusion format to generate tag‐free bi‐specific diabodies , 2010, The FEBS journal.

[7]  A. Skerra,et al.  An expression system for the E. coli fermentation of recombinant antibody Fab fragments from mice and rabbits. , 2010, Journal of AOAC International.

[8]  Thomas Müller,et al.  Development of a Mouse Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis in Humans , 2009, PLoS neglected tropical diseases.

[9]  Gang Wang,et al.  Secretory expression of human ScFv against keratin in Pichia pastoris and its effects on cultured keratinocytes , 2009, Archives of Dermatological Research.

[10]  S. Kostense,et al.  First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity. , 2008, Vaccine.

[11]  Youwei Jiang,et al.  Optimization of humanized IgGs in glycoengineered Pichia pastoris , 2006, Nature Biotechnology.

[12]  A. Casadevall.  Passive Antibody Administration (Immediate Immunity) as a Specific Defense Against Biological Weapons , 2002, Emerging infectious diseases.

[13]  C. Hanlon,et al.  Postexposure prophylaxis for prevention of rabies in dogs. , 2002, American journal of veterinary research.

[14]  H. Yunde.  Generation of Human Monoclonal Antibody Fab Fragment to Rabies Virus by Phage Display Technology , 2001 .

[15]  C. Rupprecht,et al.  The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure. , 2000, Journal of immunological methods.

[16]  R. Fischer,et al.  Towards molecular farming in the future: Pichia pastoris‐based production of single‐chain antibody fragments , 1999, Biotechnology and applied biochemistry.

[17]  J. Huston,et al.  Mammalian Cell Expression of Single–Chain Fv (sFv) Antibody Proteins and Their C–terminal Fusions with Interleukin–2 and Other Effector Domains , 1994, Bio/Technology.